FDA holding meetings with industry to gather input on reengineering program.
This article was originally published in The Gray Sheet
MEDICAL DEVICE REPORTING ABOLITION SUGGESTED BY HIMA MEMBERS at a recent meeting with Center for Devices and Radiological Health topsiders. According to FDA minutes of an April 11 session held at the Health Industry Manufacturers Association headquarters to discuss CDRH reengineering, manufacturers suggested that if FDA cannot establish the usefulness of MDR in protecting public health, it should abolish the program and regulations like MDR and use its staff elsewhere.
You may also be interested in...
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.
The FDA has released final guidance on “Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA” for the industry. The guidance brings clarity and aims at facilitating product development meetings between the FDA and the ANDA applicants for complex products.
By handing out free supplements to the clinically vulnerable, the UK government is effectively endorsing the use of vitamin D to reduce the risk and/or severity of COVID-19, although it says more research is needed.